Christopher T. Winkelmann

Author

United States Military Academy ORCID

Also Known As

C Winkelmann, C. T. Winkelmann, C.T. Winkelmann, Christopher T. Winkelmann, Christopher Winkelmann

Publications

927

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)University of Missouri Harry S. Truman Memorial Veterans' Hospital Wright State University

About

Christopher T. Winkelmann is an author at United States Military Academy specializing in medicine, osteoporosis, and bone metabolism.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	371
2	Engineering	3	3	81
3	Social Sciences	3	3	68
4	Health Sciences	2	2	82
5	Anatomy	2	2	72

Christopher T. Winkelmann

Publications

823

Citations

H-Index

Page 1

	Year	Citations
Melanoma Therapy via Peptide-Targeted α-Radiation Yubin Miao, Mark D. Hylarides, Darrell R. Fisher, Clinical Cancer Research	2005	133
Downregulation of Notch Pathway by a γ-Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model Clay L. Efferson, Christopher T. Winkelmann, Christopher Ware, Cancer Research Signaling PathwayEndocrine-related CancerMedicineCancer GrowthGlucose Uptake	2010	92
High-throughput micro-computed tomography imaging as a method to evaluate rat and rabbit fetal skeletal abnormalities for developmental toxicity studies Christopher T. Winkelmann, L. David Wise Journal of Pharmacological and Toxicological Methods Positron Emission TomographyBone ImagingDevelopmental BiologyEngineeringMedical Imaging	2009	53
A Quantitative Volumetric Micro-Computed Tomography Method to Analyze Lung Tumors in Genetically Engineered Mouse Models Brian B. Haines, Kimberly A. Bettano, Mélissa Chénard, Neoplasia	2009	49
Microimaging Characterization of a B16-F10 Melanoma Metastasis Mouse Model Christopher T. Winkelmann, Said Daibes Figueroa, Tammy L. Rold, Molecular Imaging Tumor BiologyTumor ViabilityOncologic ImagingMelanomaHistopathology	2006	49
TLD assessment of mouse dosimetry during microCT imaging Said Daibes Figueroa, Christopher T. Winkelmann, William H. Miller, Medical Physics	2008	48
Treatment of Mammary Carcinomas in HER-2 Transgenic Mice through Combination of Genetic Vaccine and an Agonist of Toll-Like Receptor 9 Luigi Aurisicchio, Daniela Peruzzi, Antonella Conforti, Clinical Cancer Research	2009	47
Role of genetic background in determining phenotypic severity throughout postnatal development and at peak bone mass in Col1a2 deficient mice (oim) Stephanie M. Carleton, Daniel J. McBride, William L. Carson, Bone Developmental BiologyPeak Bone MassGenetic BackgroundBone Morphogenic ProteinGenetics	2008	45
Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: A head-to-head comparison with alendronate Donald S. Williams, Paul J. McCracken, Mona Purcell, Bone Bone Turnover MarkersOvariectomized MonkeysBone HealthBone RemodelingGynecology	2013	37
High-resolution peripheral quantitative computed tomography and finite element analysis of bone strength at the distal radius in ovariectomized adult rhesus monkey demonstrate efficacy of odanacatib and differentiation from alendronate Antonio Cabal, Richa Y. Jayakar, Swanand Sardesai, Bone High-resolution Peripheral QuantitativeBone ImagingMedicineBiomechanicsBone Remodeling	2013	35

Page 1